In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Chromadex Corp. (NASDAQ:CDXC) reported that Champion River Ventures Ltd. has picked up 807,692 of common stock as of 2017-05-08.
The acquisition brings the aggregate amount owned by Champion River Ventures Ltd. to a total of 807,692 representing less than 2.0% stake in the company.
For those not familiar with the company, Chromadex Corporation and its subsidiaries ChromaDex, Inc., ChromaDex Analytics, Inc. and Spherix Consulting, Inc. provide research and quality-control products and services to the natural products industry. The Company allows its business units to discover, acquire, develop and commercialize ingredient technologies that address the dietary supplement, food, beverage, skin care and pharmaceutical markets. The Company operates through three segments: Ingredients, which develops, supplies and commercializes ingredient technologies; Core standards and contract services, which supplies phytochemical reference standards, which are small quantities of plant-based compounds used to research an array of attributes, reference materials and related contract services, and Scientific and regulatory consulting, which provides scientific and regulatory consulting to the clients in the food, supplement and pharmaceutical industries to manage health and regulatory risks.
A glance at Chromadex Corp. (NASDAQ:CDXC)’s key stats reveals a current market capitalization of 133.47 Million based on 38.44 Million shares outstanding and a price at last close of $3.52 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2017-03-20, Allen picked up 2,000 at a purchase price of $2.81. This brings their total holding to 2,000 as of the date of the filing.
On the sell side, the most recent transaction saw Fried unload 5,063 shares at a sale price of $1.26. This brings their total holding to 155,937.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Chromadex Corp. (NASDAQ:CDXC) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.